KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Other Non-Current Assets (2018 - 2025)

Historic Other Non-Current Assets for Progyny (PGNY) over the last 8 years, with Q3 2025 value amounting to $11.5 million.

  • Progyny's Other Non-Current Assets rose 24909.15% to $11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.5 million, marking a year-over-year increase of 24909.15%. This contributed to the annual value of $3.0 million for FY2024, which is 1231.22% down from last year.
  • As of Q3 2025, Progyny's Other Non-Current Assets stood at $11.5 million, which was up 24909.15% from $8.6 million recorded in Q2 2025.
  • Progyny's Other Non-Current Assets' 5-year high stood at $11.5 million during Q3 2025, with a 5-year trough of $536000.0 in Q2 2021.
  • Moreover, its 5-year median value for Other Non-Current Assets was $3.5 million (2023), whereas its average is $4.1 million.
  • Per our database at Business Quant, Progyny's Other Non-Current Assets surged by 70055.97% in 2022 and then tumbled by 1810.77% in 2023.
  • Over the past 5 years, Progyny's Other Non-Current Assets (Quarter) stood at $2.9 million in 2021, then soared by 35.6% to $4.0 million in 2022, then fell by 14.87% to $3.4 million in 2023, then fell by 12.31% to $3.0 million in 2024, then surged by 287.2% to $11.5 million in 2025.
  • Its last three reported values are $11.5 million in Q3 2025, $8.6 million for Q2 2025, and $8.6 million during Q1 2025.